Category: News

  • Trump mocked Clinton’s pneumonia, but social media quickly remembered that his dad died from it

    Trump mocked Clinton’s pneumonia, but social media quickly remembered that his dad died from it

    2016 presidential republican candidate Donald Trump has made fun of the democratic candidate, Hillary Clinton’s recent bout with pneumonia, imitating her stumble after the 9/11 remembrance ceremony last month. Trump is quoted saying, “Clinton is supposed to fight all of these different things and she can’t make it 15 feet to her car. Give me…

  • Sydney Trials Show Keytruda Three Times More Effective Than Chemotherapy

    Sydney Trials Show Keytruda Three Times More Effective Than Chemotherapy

    Clinical trials conducted in a Sydney hospital have shown that a new lung cancer drug called Keytruda is three times more effective than chemotherapy. The study was conducted on patients whose cancer had spread outside their lungs and whose symptoms indicated their cancer cells were”disguised” as healthy cells. Keytruda identifies these “disguises” and removes them…

  • 8 Health Groups File Suit to Force FDA to Require Graphic Cigarette Warnings

    8 Health Groups File Suit to Force FDA to Require Graphic Cigarette Warnings

    Eight health groups and several individual pediatricians filed a suit in federal court to force the U.S. Food and Drug Administration (FDA) to issue a final rule requiring graphic health warnings on cigarette packs and advertising, as mandated by a 2009 federal law. The suit was filed on Oct 4. The lawsuit was filed by the…

  • Roche lung cancer drug success adds to pressure on competitors

    Roche lung cancer drug success adds to pressure on competitors

    Lung cancer patients on pharma company, Roche’s, immune system-boosting drug Tecentriq lived on average 4.2 months longer than those taking chemotherapy reported a pivotal study. This news has pressured Bristol-Myers Squibb’s dominant position in the industry. The study results were presented at the annual European Society of Medical Oncology congress on Sunday. Bristol’s Opdivo is…

  • Depression Linked to Increased Mortality in Lung Cancer

    Depression Linked to Increased Mortality in Lung Cancer

    According to a study published in the Journal of Clinical Oncology, changes in depression symptoms over time are associated with differences in survival among patients with lung cancer. Depression symptoms are common among patients with lung cancer, therefore researchers are trying to evaluate associations between depression and mortality in patients. Researchers enrolled 1,790 patients living…

  • ‘Water Pill’ Prevents Lung Cancer Drug Resistance

    ‘Water Pill’ Prevents Lung Cancer Drug Resistance

    A new study has shown that combining lung cancer drugs with a commonly used blood pressure drug called ethacrynic acid, could make treatment more effective. The study was conducted by scientists from Fudan Unversity in China and Imperial College of London. Erlotinib is a drug used to treat patients with non-small cell lung cancer. The…

  • Vitamin E may prevent pneumonia in non-smoking elderly men

    Vitamin E may prevent pneumonia in non-smoking elderly men

    A new study by Dr. Harri Hemila from the Univeristy of Helsinki shows that Vitamin E may prevent pneumonia in non-smoking elderly men. According to a paper published in Clinical Interventions in Aging, administration of 50mg per day of Vitamin E decreased the risk of pneumonia in elderly male smokers by 72% after they quit…

  • Lung transplants coming to Vietnam hospitals in 2017

    Lung transplants coming to Vietnam hospitals in 2017

    Top Vietnamese organ transplant surgeons have stated that lung transplants will become a common practice in Vietnam in 2017. The number of lung transplants around the world has been rising through the years. Ta Ba Thang, deputy head of the Tuberculosis and Pulmonology Department under Military Hospital 103 stated that new technology and modern science,…

  • Breakthrough lung cancer drug Tagrisso now available on NHS

    Breakthrough lung cancer drug Tagrisso now available on NHS

    A last-chance drug that can lead to an “unprecedented” reduction in lung cancer tumours is now available on the National Health Service (NHS) Tagrisso, which has been dubbed as a “breakthrough” drug by its manufacturer, AstraZeneca, was granted a licence in February. The drug, which is to be taken once a day, was created for patients…